Risk Factors for Infection with Escherichia coli in Nursing Home Residents Colonized with Fluoroquinolone-Resistant E. coli

Infection Control and Hospital Epidemiology

Volumn 36, Issue 5, 2015, Pages 575-577

  Manning, Sara ^a   Lautenbach, Ebbing ^a,b   Tolomeo, Pam ^b   Han, Jennifer H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CASE CONTROL STUDY; DIABETES MELLITUS; DRUG EXPOSURE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME PATIENT; RISK FACTOR; TRACHEOSTOMY; URINARY CATHETER; ADVERSE EFFECTS; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; MICROBIOLOGY; MIDDLE AGED; NURSING HOME; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CROSS INFECTION; DIABETES COMPLICATIONS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; RISK FACTORS; TRACHEOSTOMY; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION; URINARY CATHETERS;

EID: 84993967080     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.3     Document Type: Article

References (9)

1. Vromen M, van der Ven AJ, Knols A, Stobberingh EE. Antimicrobial resistance patterns in urinary isolates from nursing home residents. Fifteen years of data reviewed. J Antimicrob Chemother 1999;44:113-116.
2. Viray M, Linkin D, Maslow JN, et al. Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance. Infect Control Hosp Epidemiol 2005;26:56-62.
3. Han JH, Maslow J, Han X, et al. Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities. J Infect Dis 2014;209:420-425.
4. Stone ND, Ashraf MS, Calder J, et al.; Society for Healthcare Epidemiology Long-Term Care Special Interest Group. Surveillance definitions of infections in long-term care facilities: revisiting the McGeer criteria. Infect Control Hosp Epidemiol 2012;33:965-977.
5. Nicolle LE, Bentley DW, Garibaldi R, Neuhaus EG, Smith PW. Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol 2000;21:537-545.
6. Das R, Perrelli E, Towle V, Van Ness PH, Juthani-Mehta M. Antimicrobial susceptibility of bacteria isolated from urine samples obtained from nursing home residents. Infect Control Hosp Epidemiol 2009;30:1116-1119.
7. Nicolle LE. The chronic indwelling catheter and urinary infection in long-term-care facility residents. Infect Control Hosp Epidemiol 2001;22:316-321.
8. Wang L, Lansing B, Symons K, et al. Infection rate and colonization with antibiotic-resistant organisms in skilled nursing facility residents with indwelling devices. Eur J Clin Microbiol Infect Dis 2012;31:1797-1804.
9. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999;26:259-266.